Ian M. McElree

Comparison of Sequential Intravesical Gemcitabine and Docetaxel vs Bacillus Calmette-Guérin for the Treatment of Patients With High-Risk Non–Muscle-Invasive Bladder Cancer

Ian M. McElree, Ryan L. Steinberg, Sarah L. Mott et al. · JAMA Network Open · 2023 · 113 citations · Full text

Medicine, Oncology, Urology +9

Sequential Intravesical Gemcitabine and Docetaxel for bacillus Calmette-Guérin-Naïve High-Risk Nonmuscle-Invasive Bladder Cancer

Ian M. McElree, Ryan L. Steinberg, Alex C. Martin et al. · The Journal of Urology · 2022 · 70 citations

Medicine, Oncology, Pharmacotherapy +11

Long-term follow-up of sequential intravesical gemcitabine and docetaxel salvage therapy for non-muscle invasive bladder cancer

Phani T. Chevuru, Ian M. McElree, Sarah L. Mott et al. · Urologic Oncology Seminars and Original Investigations · 2022 · 57 citations

Medicine, Oncology, Urology +9

Sequential Intravesical Gemcitabine and Docetaxel is an Alternative to Bacillus Calmette-Guérin for the Treatment of Intermediate-risk Non–muscle-invasive Bladder Cancer

Wei Shen Tan, Ian M. McElree, Facundo Davaro et al. · European Urology Oncology · 2023 · 36 citations

Medicine, Oncology, Urology +8

Long‐term outcomes of bladder‐sparing therapy vs radical cystectomy in BCG‐unresponsive non‐muscle‐invasive bladder cancer

Jacob Taylor, Ashish M. Kamat, Michael A. O’Donnell et al. · British Journal of Urology · 2024 · 27 citations · Full text

Medicine, Oncology, Surgery +15